

The 29-year-old tested positive for the heart-boosting drug meldonium in January at the Australian Open and was given a two-year ban by the International Tennis Federation (ITF) in June.
But CAS, sport’s highest court, announced it has reduced that by nine months, meaning the five-time grand slam winner will be eligible to play again on April 26, 2017, four weeks before the French Open.
Advertisement
Hide AdAdvertisement
Hide Ad